Hematologist
CION Cancer Clinics
Bone marrow transplant for myelofibrosis: is it right for you? | CION Cancer Clinics
A donor stem cell transplant is the only treatment that can remove myelofibrosis from the marrow. It also carries serious, sometimes life-threatening risks, so it is usually considered for fitter people with intermediate-2 or high-risk disease who have a suitable donor. This page explains who is assessed, what the pathway involves, who it does not suit and the questions to ask your haematologist. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can a bone marrow transplant clear myelofibrosis?
- Who is usually considered for a transplant?
- How does a transplant compare with staying on tablets?
- What happens from the first discussion to after the transplant?
- What are the main risks, and who is it not right for?
- What do families often believe about transplant?
- What do the transplant words mean?
- Common questions about transplant for myelofibrosis
The short answer
Can a bone marrow transplant clear myelofibrosis?
A donor stem cell transplant is the only treatment that can clear myelofibrosis from the marrow for the long term. It is also one of the riskiest treatments in medicine, so it is offered only when the danger of the disease outweighs the danger of the transplant.
What the transplant actually does
Strong treatment first clears out your own diseased marrow. Healthy blood-forming stem cells from a matched donor are then given through a drip, rather like a transfusion. They settle in the bones and begin making new blood. The donor's immune cells also attack any remaining myelofibrosis cells, which is a large part of why it works.
Why it is not offered to everyone
Tablets such as ruxolitinib ease the spleen and symptoms, but they do not remove the disease. A transplant can, but serious complications and deaths linked to the transplant itself are a real possibility. For someone with slow, lower-risk disease, that trade usually does not make sense. For someone with higher-risk disease who is fit, it often does.
Where it is done
Transplants for myelofibrosis are carried out at specialised transplant centres. CION's haematology team assesses whether you should be referred, presents your case at a tumour board and coordinates with qualified centres.
Deciding together
Who is usually considered for a transplant?
No single factor decides it. Your haematologist weighs these together, and the answer can change as the disease changes.
Your risk group
Scores such as DIPSS place myelofibrosis into lower or higher risk groups. Transplant is mainly discussed for intermediate-2 and high-risk disease.
Your fitness
Age matters, but general health matters more. Heart, lung, kidney and liver function, and how active you are day to day, all count.
A suitable donor
A matched brother or sister is checked first. If none matches, an unrelated or half-matched family donor may be searched for.
Signs the disease is moving
Some findings push the conversation earlier.
For example
- Rising blasts in the blood
- Needing regular transfusions
- High-risk gene changes
- Tablets no longer controlling the spleen
Not sure whether this applies to you?
Ask an oncologistSide by side
How does a transplant compare with staying on tablets?
These are general patterns, not predictions for you. Many people stay on tablets for a time and move to transplant assessment later if the disease changes, so the two paths are not always a one-time choice.
Donor transplant
JAK inhibitor tablets and supportive care
Can remove the disease from the marrow
Controls spleen and symptoms; the disease remains
Serious early risks, including life-threatening infection
Lower early risk; side effects are usually manageable
Weeks in hospital and months of close follow-up
Mostly outpatient visits and blood tests
Needs a suitable donor and a specialised centre
Can be managed nearer home
The pathway
What happens from the first discussion to after the transplant?
-
Assessment and tumour board
Your haematologist reviews your risk score, bone marrow and gene reports, and fitness tests, then discusses your case with other specialists.
-
Tissue typing and donor search
HLA typing, a blood test that checks the markers used for matching, is done for you and your brothers and sisters at a qualified laboratory. Ask where it will be sent and how long it takes.
-
Getting ready
Tablets may be continued to shrink the spleen before transplant. Heart, lung, dental and infection checks follow, along with counselling for the family.
-
Conditioning and the transplant
Chemotherapy, sometimes with other medicines, clears the marrow. The donor cells are then given through a drip.
-
Waiting for the new marrow to work
Counts stay very low for a period, so infection control is strict. In myelofibrosis the new marrow can be slower to start working.
-
Recovery and long follow-up
Frequent clinic visits continue for months, with close watching for infection and graft-versus-host disease.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What are the main risks, and who is it not right for?
The biggest dangers come in the first months: serious infection, bleeding, organ damage from the conditioning treatment, and graft-versus-host disease. Some people die from these complications rather than from myelofibrosis.
Graft-versus-host disease
The donor's immune cells can attack your skin, gut, liver or other organs. It ranges from a mild rash to a long-term illness needing ongoing treatment. Medicines to prevent it are given, but it cannot always be avoided.
Problems more common in myelofibrosis
Scarred marrow and a large spleen can slow the new cells from taking hold, so graft failure is more of a concern than in some other blood cancers. The disease can also come back after transplant.
Who it usually does not suit
People with lower-risk disease and few symptoms, people with serious heart, lung or kidney problems, and people whose fitness is too limited for intensive treatment. For them, tablets, transfusions and good supportive care are often the wiser path. This page cannot tell you your own chances; your transplant team will discuss them with you directly.
Commonly believed
What do families often believe about transplant?
"The donor has to have an operation on their bones."
Most donors today give stem cells from the blood, through a machine, after injections that move the cells into the bloodstream. Collection from the hip bone is less common. The donor recovers quickly in most cases.
"If there is a matched sibling, we should do it straight away."
A donor makes transplant possible, not automatically right. If your disease is lower risk, the transplant may carry more danger than the disease does for now. Timing is the real decision.
"Older people can never have one."
Reduced-intensity conditioning, a gentler preparation, has made transplant possible for some older adults. Fitness and other illnesses matter more than the number on the birth certificate.
"We should wait until the tablets stop working."
Waiting can mean the chance passes, because the disease may progress or fitness may fall. If you are in a higher risk group, ask early whether you should be referred for assessment.
Words you will hear
What do the transplant words mean?
- Allogeneic transplant
- A transplant using stem cells from a donor. It is the type used for myelofibrosis.
- HLA match
- How closely the donor's tissue markers match yours. A closer match lowers some risks.
- Haploidentical donor
- A half-matched family member, often a parent, child or sibling.
- Conditioning
- The chemotherapy, sometimes with other treatment, given before the donor cells to make space and lower your immune defences.
- Engraftment
- The point at which the donor cells start making blood counts.
- Chimerism
- A test showing how much of your blood now comes from the donor.
Questions we are asked
Common questions about transplant for myelofibrosis
Is a bone marrow transplant the only way to get rid of myelofibrosis?
Yes. A donor stem cell transplant is currently the only treatment that can remove the disease from the marrow. Other treatments control the spleen, symptoms and blood counts. That does not make transplant right for everyone, because its risks can outweigh the benefit when the disease is slow.
Does CION do the transplant?
CION's haematology team assesses whether a transplant should be considered, presents your case at a tumour board and coordinates referral and care with qualified transplant centres. Ask your haematologist which centre is suggested, why, and how care will be shared before and after.
Can my own stem cells be used?
No. An autologous transplant, using your own cells, does not help myelofibrosis because those cells carry the disease. A donor is needed. Brothers and sisters are usually tested first, then unrelated or half-matched family donors if there is no full match.
What if no brother or sister matches?
A half-matched family member or an unrelated donor from a registry may be possible. Finding an unrelated match can be harder for people of Indian ancestry, because registries hold fewer Indian donors. Your team will explain the options and how long a search might take.
Will I need to stop ruxolitinib before transplant?
Many teams continue it up to shortly before conditioning to keep the spleen and symptoms under control, then taper it in a planned way. The timing is set by your transplant team. Do not stop or change it on your own, because symptoms can return quickly.
Does the spleen need to be removed first?
Usually not. Most people go to transplant with their spleen in place, sometimes after tablets have shrunk it. Removing it or treating it with radiotherapy is considered only in selected cases, because surgery itself carries risk. Ask your team what they recommend for you and why.
How long does recovery take?
Recovery is measured in months rather than weeks. You will stay near the transplant centre for frequent checks at first. Energy, appetite and immunity return gradually, and some people have longer-term effects to manage. Plan for a family member to be available throughout.
Do schemes or insurance cover a transplant?
Some schemes, including Aarogyasri, PM-JAY, CGHS, ECHS and EHS, and many cashless insurance policies, may cover part of a transplant at an empanelled centre. Rules change and donor search costs are handled differently, so ask for a written estimate and check your current entitlement.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Chronic Myeloproliferative Neoplasms Treatment (PDQ) - Patient Version
- National Cancer Institute — Stem Cell Transplants in Cancer Treatment
- Leukemia & Lymphoma Society — Myelofibrosis
- Blood Cancer UK — Understanding blood cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Bone marrow transplant guideHow transplants work across all blood cancersDIPSS risk scoring in myelofibrosisThe score that decides when transplant is discussedRuxolitinib in myelofibrosisThe main alternative to transplantMyelofibrosis treatment cost in IndiaWhat drives the cost and what schemes cover
Talk to us
Wondering if transplant should be discussed?
Share your reports and risk score with us. The CION haematology team will review your case and explain whether referral for transplant assessment makes sense. One helpline serves every CION centre.